FDA Oncology medical reviewers wrote more than 500 articles for peer-reviewed journals from 2018-2023

An oncologist doesn’t have to be a researcher to use Expanded access for their patients with cancer – FDA Oncology

FDA approves safety labeling changes regarding DPD deficiency for fluorouracil injection products – FDA Oncology

FDA Oncology: FDA Oncology’s Dan Suzman discusses approaches to oncology trials and regulatory issues

OCE Project Community provides information for patients, consumers and caregivers – FDA Oncology

Dive into the world of Precision Medicine this Myeloma and Colorectal Cancer Awareness Month – FDA Oncology

Talazoparib in Combination With Enzalutamide for Prostate Cancer – FDA Oncology

A big thank you to all our panelists for Conversations on Cancer event – FDA Oncology

Noha N. Soror: Honored to be amongst such an incredible group

Elad Sharon: Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma!